Simple Treatment for Disruptive Snoring and Obstructive Sleep Apnea Now Available

The latest device available to help the 40% of adults who suffer from snoring and obstructive sleep apnea (OSA) is now available in Canada through a Victoria, B.C. distributor.

The Aveo Tongue Stabilizing Device (aveoTSD), developed in New Zealand by an orthodontist after his father died of chronic sleep apnea, is simple and cost-effective. Unlike other solutions to sleep disordered breathing, the aveoTSD fits easily in the palm of a hand.

While snoring has long been the topic of many jokes, few people realize it could be a symptom of serious health issues, as well as causing misery in countless relationships that break up because couples find it impossible to sleep together.

"No more moving to the couch in the middle of the night," says Leah Giles of Victoria, Canada, whose husband was a snorer. "My husband had surgery for his snoring a few years ago, which only worked for a short time. We got the aveoTSD and it’s great. It helps with his breathing while he’s sleeping, and allows me to get a good night asleep."

Sleep wellness is now joining exercise and diet as a requirement for complete health. People with obstructive sleep apnea stop breathing during sleep when the tongue relaxes and blocks the airway. Along with snoring, a partial blocking of the airway, these sleep disorders can lower oxygen levels in the blood, leading to an increased risk of stroke, depression and debilitating daytime fatigue.

As a first-line primary health care initiative, the aveoTSD has been approved by Health Canada and the U.S. Food and Drug Administration (FDA) as a medical device. Made from a soft medical silicone, the aveoTSD works by simply keeping the tongue forward during sleep, opening the airway and stopping the vibrations that cause snoring.

With the potential for promoting health and addressing family disruption, the new device has advantages over other treatments that require dental fittings, face masks, a machine pump, or surgery. Retailing at $150 (US), price is another obvious advantage of the aveoTSD.

"I had another good night," says OSA sufferer Gerry Bannerman of Surrey, Canada of his aveoTSD. "I’m excited about this product – finally, a solution that works."

For further information on the aveoTSD go to www.aveosleep.ca. AveoTSD is distributed in Canada by Ethics International Business and Trade.

For further information, or to arrange a media interview, call 1-866-440-AVEO (2836)

This release is also available at www.aveosleep.ca/aveotsdmedia.html